Hydrocodone Bitartrate

CHEMBL3989677 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

989.0 g/mol

LogP

—

Phase

4

The bitartrate salt form of hydrocodone, an opioid analgesic used for moderate to severe pain management and antitussive purposes. This salt form improves stability and solubility in oral formulations. Like all opioids, it carries significant risks of respiratory depression, dependence, and misuse.

分子量

989.0000 g/mol

TPSA

313.00 Å²

治療領域

Pain Management Obesity Lymphoma Breast Cancer Chronic Pain

作用機序

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O

InChI

InChI=1S/C18H21NO3.C4H6O6.2H2O/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;5-1(3(7)8)2(6)4(9)10;;/h3,6,11-12,17H,4-5,7-9H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10);2*1H2/t11-,12+,17-,18-;;;/m0.../s1

Molecular Formula

C44H64N2O23

HBD / HBA

13 / 25

回転可能結合数

8

重原子数

69

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The bitartrate salt form of hydrocodone, an opioid analgesic used for moderate to severe pain management and antitussive purposes. This salt form improves stability and solubility in oral formulations. Like all opioids, it carries significant risks of respiratory depression, dependence, and misuse.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Hydrocodone Bitartrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989677. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23724881. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Hydrocodone Bitartrate PillFYIで

構造

クイックデータ

分子式: C44H64N2O23
同義語: 19

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.